-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) PT Raised to $95 at H.C. Wainwright
-
-
-
-
-
-
-
Halozyme elects Jim Lang to board of directors
-
-
-
-
-
-
-
Halozyme Therapeutics, Inc. Announces Proposed Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) PT Raised to $91 at Citizens JMP
-
-
-
-
-
-
-
HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG FIRST QUARTER 2025 RESULTS
-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) Provides Update on Non-Binding Proposal to Combine with Evotec (EVO)
-
-
-
-
-
-
-
HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS
-
1,199,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

